𝔖 Bobbio Scriptorium
✦   LIBER   ✦

NHL-3 protocol six-drug combination chemotherapy for non-hodgkin's lymphoma

✍ Scribed by Benjamin Koziner; Robert Sklaroff; Claudia Little; David J. Straus; Burton J. Lee III; Bayard D. Clarkson; Dominic Labriola; H. Tzvi Thaler; Charles W. Young; Lourdes Z. Nisce; Herbert Oettgen

Publisher
John Wiley and Sons
Year
1984
Tongue
English
Weight
747 KB
Volume
53
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Multicentre combined chemotherapy protoc
Multicentre combined chemotherapy protocol for large cell advanced non hodgkin's lymphoma
✍ J. Dumont; P. Charpy-Validire; V. Mosseri; J. Gabarre; C. Belanger; F. Turpin; J πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 702 KB

## Abstract Between October 1985 and October 1989, 75 previously untreated patients with stage III and IV non Hodgkin's lymphoma, large cell type, were treated with an alternating weekly chemotherapy regimen including the following drugs: week 1: Doxorubicin, vincristine, cyclophosphamide, bleomyci

CCNU in combination chemotherapy for adv
CCNU in combination chemotherapy for advanced histologically unfavorable non-Hodgkin's lymphoma
✍ Don V. Jackson; Hyman B. Muss; Fred Richards; Douglas R. White; Charles L. Spurr πŸ“‚ Article πŸ“… 1983 πŸ› Springer 🌐 English βš– 496 KB

During a 3-year period 39 evaluable patients with stage III and IV non-Hodgkin's lymphomas and unfavorable histologies were treated with a unique chemotherapeutic regimen based on a modified CHOP combination to which was added the nitrosourea, CCNU. Complete response was observed in six of 15 (40%)

Immunotoxin combined with chemotherapy f
Immunotoxin combined with chemotherapy for patients with AIDS-related non-Hodgkin's lymphoma
✍ David T. Scadden; David P. Schenkein; Zale Bernstein; Barry Luskey; John Doweiko πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 101 KB πŸ‘ 2 views

The objective of this study was to develop and test a combined therapeutic approach for patients with AIDS-related lymphoma (ARL), employing agents with independent mechanisms of action and nonoverlapping toxicity. This study was designed to test the feasibility and tolerance of combining low dose c

An alternating chemotherapy combination
An alternating chemotherapy combination (macoble) for intermediate and high-grade non-hodgkin's lymphoma
✍ M. Harding; L. McNulty; J. Paul; F. Lee; D. Dunlop; M. Soukop πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 485 KB πŸ‘ 1 views

48 patients with intermediate or high-grade non-Hodgkin's lymphomas (NHL) received a CHOP based combination with the addition of etoposide on days 1 and 2, bleomycin days 1 and 10 and methotrexate 1.5 g/m2 on day 10 (MACOBLE). Their median age was 59 years, 20 (42 per cent) had an ECOG performance s